Still a work in progress..On the stockhouse banner, they mention where they are in testing.
Still a ways to go, but the stock should be higher than where it is.
Some major catch up coming. IMO.
Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026